2017
DOI: 10.1155/2017/1937107
|View full text |Cite
|
Sign up to set email alerts
|

Primary Pulmonary Lymphoma Presenting with Superior Vena Cava Syndrome in a Young Female

Abstract: Primary Pulmonary Diffuse Large B Cell Lymphoma (PPDLBCL) is an extremely rare entity, which exhibits an aggressive behavior by compressing local blood vessels. It represents only 0.04% of all lymphoma cases and is extremely rare in young age. We present a case of a primary pulmonary lymphoma with superior vena cava syndrome (SVCS) in a young female. 27-year-old African American female presented with fever, cough, and facial puffiness for 2 weeks and unintentional weight loss. Chest examination showed decrease… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 12 publications
(11 reference statements)
0
11
0
Order By: Relevance
“…19 However, in another young female with PPDLBCL who presented with SVC syndrome, involved field radiotherapy was initiated to rapidly relieve symptoms, followed by R-CHOP chemotherapy. 2 As an aggressive subtype, PPDLBCL has a poorer prognosis compared with lung MALT lymphoma, intensive chemotherapy is essential especially for those who refused surgery just like our patient.…”
Section: Dovepressmentioning
confidence: 85%
See 1 more Smart Citation
“…19 However, in another young female with PPDLBCL who presented with SVC syndrome, involved field radiotherapy was initiated to rapidly relieve symptoms, followed by R-CHOP chemotherapy. 2 As an aggressive subtype, PPDLBCL has a poorer prognosis compared with lung MALT lymphoma, intensive chemotherapy is essential especially for those who refused surgery just like our patient.…”
Section: Dovepressmentioning
confidence: 85%
“…1 With regard to the aggressive subset termed primary pulmonary diffuse large B cell lymphoma (PPDLBCL), we have little information about its biological characteristics, optimized therapeutic protocols, and outcomes since less than 40 cases have been reported. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] Here, we present an instructive PPDLBCL case mimicking lung metastasis in a heavily treated breast cancer patient. In view of the patient's nonspecific discomfort, isolated subpleural nodule, and definite history of metastatic breast cancer, it could easily have been misdiagnosed as lung metastasis.…”
Section: Introductionmentioning
confidence: 99%
“…[ 8 ] Among them, DLBCL constitutes 1% of the cases of primary lymphoma of the lung, accounting for 0.4% of all the lymphomas. [ 9 ] The clinical features of PPL are not specific, and lung DLBCL can be seen in immunodeficient patients having a vascular collagen disease with or without potential pulmonary fibrosis, patients having AIDS, and patients taking cyclosporine after transplantation. Although the mechanisms of the increased incidence of lymphoproliferative diseases in immunodeficient patients are not fully understood, deterioration in immunoregulation, chronic antigenic stimulation, and tumor suppressor system dysregulation are thought to be the main reasons for it.…”
Section: Discussionmentioning
confidence: 99%
“…Extrapulmonary diseases were also excluded; therefore, we concluded that primary pulmonary lymphoma (PPL) was likely. PPL is an extremely rare form of lymphoma with an incidence of 0.4% [2]; for the sake of making a diagnosis of PPL, extrapulmonary diseases must be ruled out [3]. Approximately half of PPL cases have no symptoms or lack specific respiratory manifestations, such as cough, dyspnea, chest pain and so on [4].…”
Section: To the Editormentioning
confidence: 99%